Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Int J Biol Markers. 2011 Sep 21;26(3):141–152. doi: 10.5301/JBM.2011.8613

Fig. 4.

Fig. 4

Performance of a urine multimarker panel in the discrimination of stage I breast cancer patients from controls. The top performing urine biomarker panel for the discrimination of stage I breast cancer patients from healthy controls was identified using the Metropolis-Monte Carlo (MMC) algorithm. The performance of this 3-biomarker panel consisting of FSH, MPO, and OC in distinct training and validation sets is presented according to ROC analysis. AUC, area under the curve; CI, confidence interval; SN, sensitivity; SP, specificity.